Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Fangxuan Li

Indoleamine-2,3-Dioxygenase and Interleukin-6 Associated With Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer

English

Related publications

RB-Pathway Disruption Is Associated With Improved Response to Neoadjuvant Chemotherapy in Breast Cancer

Clinical Cancer Research

Cancer Research

English

Immunotherapeutic Suppression of Indoleamine 2,3-Dioxygenase and Tumor Growth With Ethyl Pyruvate

Cancer Research

Cancer Research

English

Indoleamine 2,3-Dioxygenase 1 (IDO1)

Science-Business eXchange

English

Multiagent Neoadjuvant Chemotherapy and Tumor Response Are Associated With Improved Survival in Pancreatic Cancer

Gastroenterology

English

Osteopontin and Vasculogenic Mimicry Formation Are Associated With Response to Neoadjuvant Chemotherapy in Advanced Breast Cancer

OncoTargets and Therapy

English

Critical Role of Indoleamine 2,3-Dioxygenase in Tumor Resistance to Repeated Treatments With Targeted IFN

Molecular Cancer Therapeutics

Cancer Research

English

MRP1 but Not MDR1 Is Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Disease Markers

Clinical Biochemistry

Molecular Biology

English

Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer

Journal of Medical – Clinical Research & Reviews

English

Correction to “A Pt(IV) Pro-Drug Preferentially Targets Indoleamine-2,3-Dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy”

Journal of the American Chemical Society

Surface Chemistry

English